The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease

Journal of Neuroscience Methods

Volumn 67, Issue 2, 1996, Pages 103-112

  Hume, Susan P ^a   Lammertsma, Adriaan A ^a   Myers, Ralph ^a   Rajeswaran, Suren ^a   Bloomfield, Peter M ^a   Ashworth, Sharon ^a   Fricker, Rosemary A ^b   Torres, Eduardo M ^b   Watson, Ian ^a   Jones, Terry ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dopamine receptor; Dopamine transporter; Fluorodopa; Positron emission tomography; Raclopride; Rat; RTI 121; Schering 23390

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; ENTACAPONE; EPLIVANSERIN; FLUORODOPA F 18; IBOTENIC ACID; OXIDOPAMINE; RACLOPRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; HUNTINGTON CHOREA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT;

EID: 0030220317     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(96)00010-6     Document Type: Article

References (33)

1. 18F]6-fluorodopa, Appl. Radiat. Isot., 37: 877.
2. Bloomfield, P.M., Rajeswaran, S., Spinks, T.J., Hume, S.P., Myers, R., Ashworth, S., Clifford, K.M., Jones, W.F., Byars L.G., Young, J., Andreaco, M., Williams, C.W., Lammertsma, A.A. and Jones, T. (1995) The design and physical characteristics of a small animal positron emission tomograph. Phys. Med. Biol., 40: 1105-1126.
3. Brooks, D.J. (1993) Functional imaging in relation to parkinsonian syndromes, J. Neurol. Sci., 115: 1-17.
4. 11C]RTI-121 - A potential radioligand for PET studies of the dopamine transporter, J. Labelled Cmpd. Radiopharm., 35: 483-484.
5. Carroll, F.I., Kotian, P., Dehghani, A., Gray, J.L., Kuzemko, M.A., Parham, K.A., Abraham, P., Lewin, A.H., Boja, J.W. and Kuhar, M.J. (1995) Cocaine and 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter, J. Med. Chem., 38: 379-388.
6. 18F]6-fluoro-L-3,4,-dihydroxyphenylalanine in the hooded rat, J. Neurochem., 48: 601-608.
7. 1 receptors in rat cortical areas, neostriatum, olfactory bulb and hippocampus in relation to endogenous dopamine contents, Synapse, 2: 395-405.
8. 11C-raclopride in living human brain - a search for extrastriatal central D2-dopamine receptors by PET, Psychopharmacology, 94: 471-478.
9. 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography, Appl. Radiat. Isot., 37: 1039.
10. Halldin, C. (1991) Radioligands for dopamine receptors for PET studies; benzamides and ligands for dopamine D-1 receptors. In J.C. Baron, D. Comar, L. Farde, J.L. Martinot and B. Mazoyer (Eds.), Brain Dopaminergic Systems: Imaging with Positron Tomography, Kluwer, The Netherlands, pp. 23-38.
11. Hichwa, R. (1994) Are animal scanners really necessary for PET? J. Nucl. Med., 35: 1396-1397.
12. Hoffman, E.D., Huang, S.-C. and Phelps, M.E. (1979) Quantitation in positron emission computed tomography: I. Effect of object size, J. Comput. Assist. Tomogr., 3: 299-308.
13. Hume, S.P., Myers, R., Bloomfield, P.M., Opacka-Juffry, J., Cremer, J.E., Ahier, R.G., Luthra, S.K., Brooks, D.J. and Lammertsma, A.A. (1992) Quantitation of carbon-11 labelled raclopride in rat striatum using positron emission tomography, Synapse, 12: 47-54.
14. 11C]raclopride binding in rat striatum, quantified using PET, Synapse, 21: 45-53.
15. Innis, R.B. (1994) Single-photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease, Eur. J. Nucl. Med., 21: 1-5.
16. Kaakkola, K. and Wurtman, R.J. (1993) Effects of catechol-O-methyl-transferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum, J. Neurochem., 60: 137-144.
17. 3H-raclopride. Biochem. Pharmacol., 34: 2251-2259.
18. 11C]raclopride studies, J. Cereb. Blood Flow Metab., in press.
19. Lammertsma, A.A., Hume, S.P., Myers, R., Bloomfield, P.M., Rajeswaran, S. and Jones, T. (1993) RAT-PET: A bridge between ex vivo animal and in vivo patient studies. In K. Uemura, N.A. Lassen, T. Jones and I. Kanno (Eds.), Quantification of brain function: Tracer kinetics and Image Analysis in Brain PET. Excerpta Medica, Amsterdam. pp. 321-326.
20. Lammertsma, A.A., Hume, S.P., Myers, R., Ashworth, S., Bloomfield, P.M., Rajeswaran, S., Spinks, T. and Jones, T. (1995) PET scanners for small animals, J. Nucl. Med., 36: 2391-2392.
21. Leenders, K.L. (1991) [18F]Fluorodopa uptake in brain. In J.C. Baron, D. Comar, L. Farde, J.L. Martinot and B. Mazoyer (Eds.). Brain Dopaminergic Systems: Imaging with Positron Tomography, Kluwer. The Netherlands, pp. 97-110.
22. 18F]fluoro-L-DOPA in rats, monkeys and humans. Life Sci., 47: 149-157.
23. McQuade, R.D., Ford, D., Duffy, R.A., Chipkin, R.E., Iorio, L.C. and Barnett, A. (1988) Serotonergic component of SCH 23390: in vitro and in vivo binding analyses, Life Sci., 43: 1861-1869.
24. Myers, R., Hume, S.P., Ashworth, S., Lammertsma, A.A., Bloomfield, P.M., Rajeswaran, S. and Jones, T. (1996) Quantification of dopamine receptors and transporter in rat striatum using a small animal PET scanner. In R. Myers, V. Cunningham, D. Bailey and T. Jones (Eds.). Quantification of brain function using PET. Academic Press, San Diego. USA, in press.
25. Patlak, C.S., Blasberg, R.G. and Fenstermacher, J.D. (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data, J. Cereb. Blood Flow Metab., 3: 1-7.
26. Paxinos, G. and Watson, W. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd Edn. Academic Press. NSW. Australia.
27. Perese, D.A., Ulman, J., Viola, J., Ewing, S.E. and Bankiewicz, K.S. (1989) A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res., 494: 285-293.
28. 18F]fluoro-L-DOPA in rat. J. Cereb. Blood Flow Metab., 10: 707-719.
29. 2 receptor antagonist, J. Pharmacol. Exp. Ther., 262: 759-768.
30. Robb, R.A. and Hanson, D.P. (1991) A software system for interactive and quantitative visualization of multidimensional biomedical images, Aust. Phys. Eng. Sci. Med., 14: 9-30.
31. 18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease Neurology, 44: 1292-1297.
32. Spencer, S.E. and Wooten, G.F. (1984) Phamacologic effects of L-dopa are not closely linked temporally to striatal dopamine concentration, Neurology, 34: 1609-1611.
33. Torres, E.M., Fricker, R.A., Hume, S.P., Myers, R., Opacka-Juffry, J., Ashworth, S., Brooks, D.J. and Dunnett, S.B. (1995) Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner, NeuroReport. 6: 2017-2021.